You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

55 Results
Guidelines and Advice
Drug
Other Name(s): Proleukin® (interleukin-2)
Apr 2024
Drug
Other Name(s): Arimidex®
Oct 2024
Drug
Other Name(s): Zytiga®
Aug 2024
Drug
Other Name(s): Yervoy®
Aug 2024
Drug
Other Name(s): Inlyta®
Apr 2024
Drug
Other Name(s): Giotrif®
Apr 2024
Drug
Other Name(s): Alecensaro®
Apr 2024
Drug
Other Name(s): Agrylin®
Apr 2024
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    anastrozole
Apr 2024
Regimen
Cancer Type:
Breast, 
Gynecologic, 
Endometrial
Intent: Palliative
Funding:
ODB - General Benefit
    anastrozole
Apr 2024
Regimen
Cancer Type:
Gastrointestinal, 
Gastrointestinal Stromal Tumours, 
Sarcoma, 
GIST
Intent: Adjuvant
Funding:
ODB - General Benefit
    iMAtinib - Refer to listed Health Canada indications for generic imatinib formulations. Patients must meet generic substitution policies for access to Gleevec®
Oct 2024

Pages